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ABSTRACT
Strawberries and Gut Health in Postmenopausal Women
Morgan T. MacNeill
The gut microbiota has been implicated in both health and disease. As such, diet is a
significant determinant of gut health, whereby diet induced dysbiosis is associated with
cardiometabolic risk. Interestingly, a higher proportion of Firmicutes and a lower
proportion of Bacteroidetes are implicated in obesity. Strawberry polyphenols have
been shown to reduce cardiovascular disease risk in addition to exhibiting prebiotic
activity by increasing probiotic bacteria in the gut. Polyphenols have also been shown to
reduce the ratio of Firmicutes to Bacteroidetes. Therefore, dietary modifications such as
strawberry consumption may help improve health outcomes through the gut. The
objective of this study was to analyze whether 13 g freeze dried strawberry powder (~1
cup/d fresh) consumption reduces the Firmicutes:Bacteroidetes ratio and increases
microbial diversity and beneficial bacteria like Lactobacillus and Bifidobacterium. This
study was a 5-week free-living diet intervention trial conducted at California Polytechnic
State University, San Luis Obispo and The Eye Medical Center of Fresno. Participants
(n=10) had a mean age of 60.5 ± 9.13 years and had a mean body weight of 74.71 ±
10.61 kg. The participants completed a 3-week washout before a 2-week diet
intervention. Participants maintained their normal diet throughout the study while
eliminating foods high in polyphenols and probiotics. Upon completion of the study, no
significant differences were found for body weight (p=0.22) or BMI (p=0.26). Likewise,
no significant differences were found for macronutrient, vitamin, or mineral intake
except for sugar (p=0.03), vitamin B12 (p=0.03), and fruit (p=0.0014). Bacteria
abundance and diversity were not found to be statistically significant following
intervention. Since strawberry supplementation was not associated with a significant
change in the relative abundance of bacteria with the dose and duration administered, a
randomized controlled trial would better determine the effect of strawberry
consumption on gut health.
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1. INTRODUCTION
Recent research has identified an association between the gut microbiota and overall
health. Known factors such as genetics and lifestyle choices are shown to influence the
composition of the gut microbiota. Specifically, research has shown a significant
relationship between diet and the gut microbiota.1 Diet affects a variety of variables
related to gut health. For instance, diet-induced dysbiosis (imbalance of healthy and
harmful gut bacteria) has been linked to atherosclerosis, obesity, and type 2 diabetes.2
Additionally, research has demonstrated the association between the ratio of the phyla
Firmicutes and Bacteroidetes and specific health outcomes. For example, an increased
Firmicutes:Bacteroidetes (F:B) ratio potentially contributes to adiposity through greater
energy harvest and activation of lipopolysaccharide (LPS) accompanied by changes in
the intestinal barrier integrity.3
Recent literature has also identified a relationship between sex hormones, the gut
microbiota, and their link to various disease states. Specifically, postmenopausal women
see a decline in estrogen as they begin menopause4 which is accompanied by an
increased risk for CVD.5 Research has found that CVD risk may be related to the gut
microbiota’s ability to process estrogen.6 Lifestyle choices like diet may exacerbate this
process by contributing to a state of dysbiosis, and therefore, resulting in decreased
ability to metabolize estrogen.6 As it stands, postmenopausal women have a high
Firmicutes:Bacteroidetes ratio compared to men, and reduced baseline short chain fatty
acid (SCFA) metabolism, both of which may also contribute to the pathogenesis of CVD. 7
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As such, diet, especially fruit intake, may be an effective approach to improve health
outcomes through the gut. Namely, polyphenols found in strawberries have been
reported to stimulate growth of commensal and probiotic bacteria while selectively
inhibiting pathogen growth.8
Previous diet intervention trials have investigated the consumption of various high
polyphenol fruit, berry polyphenols, and berries on the human gut microbiota profile9-19
whereas studies that assess the impact of strawberry consumption on the gut have yet
to be investigated. The effect of strawberry consumption on the composition and
diversity of the gut microbiota in overweight postmenopausal women is currently
unknown.
Given the documented negative impact of lifestyle choices, including diet, on gut
health,1 and the potential for strawberry consumption to mitigate these effects, daily
strawberry intake could be an alternative to expensive treatment methods that can
generate unwanted side-effects. Thus, the objective of this study is to assess and
determine the effect of strawberry consumption on the diversity and composition of the
gut microbiota. It is hypothesized that daily consumption of 13 g (~1 cup fresh
strawberries) freeze-dried strawberry powder will reduce the ratio of Firmicutes to
Bacteroidetes while also increasing the microbial diversity and the abundance of several
probiotic bacteria including Bifidobacterium and Lactobacillus.

2

2. LITERATURE REVIEW
2.1

Gut Microbiota in Healthy Individuals

The bacteria that inhabit the gut have the potential to influence overall human health
and well-being. Gut microbes produce large numbers of bioactive compounds, including
vitamins and short-chain fatty acids (SCFAs), that promote cellular mechanisms which
maintain tissue integrity.1 However, while a large majority of the bacteria are
innocuous, they may also play a role in chronic diseases.20 Recent findings have
consistently observed that low bacterial diversity is associated with different diseases
and health conditions including obesity and intestinal inflammation.21 As such, the exact
role of the gut microbiota in the onset of disease is still being explored. That is, does
disease precede changes to the microbiota composition or do changes in the gut
composition lead to disease. Nonetheless, microbial diversity has been linked with the
metabolic functions of the gut bacteria, and thus has the potential to influence human
health.21
2.1.1 Composition of the human gut microbiota
The human gastrointestinal tract represents a large microbial ecosystem, housing
several trillion microbial cells, specifically bacteria.22 To date, there have been over 50
bacterial phyla identified,23 with Bacteroidetes and Firmicutes representing
approximately 90% of the gut microbiota24; Proteobacteria, Actinobacteria,
Verrucomicrobia, and Fusobacteria exist in smaller proportions (Figure 1).24
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Figure 1. Predominant taxonomic gut microbiota composition, Rinninella, 2019.24
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2.1.1.1

Predominant gut bacteria and their functions

2.1.1.1.1 Bacteroidetes
The Bacteroidetes phylum make up ~23% of the gut composition25 and includes genera
known for their role in human health. Bacteroides (approximately 75% of the
Bacteroidetes phylum26) and Prevotella are two genera within the Bacteriodetes phylum
which specialize in the metabolic conversion of protein and complex carbohydrates (i.e.
plant polysaccharides like cellulose, starch, pectins, and xylans) to their respective
metabolites. In addition, the Bacteroidetes phylum are major producers of the SCFA
propionate27 while some Bacteroides spp. deconjugate bile acids.28
2.1.1.1.2 Firmicutes
The Firmicutes phylum constitutes ~50%-80% of the gut microbiota.28 Notable genera
include Clostridium, Lactobacillus, Bacillus, Enterococcus, and Ruminicoccus; Clostridium
represents 95% of the Firmicutes phylum.24 Most butyrate productions occurs in the
Firmicutes phylum29 with several microbial communities capable of fermenting
carbohydrates to lactate.28 For instance, Streptococcus spp. ferment simple sugars into
lactate, and the lactate is converted into propionate by Veillonella spp.28 Likewise, the
Lactobacillus spp. produce lactic acid from carbohydrate fermentation and
Ruminococcus spp. degrade resistant starch to produce acetate.28
2.1.1.1.3 Actinobacteria
Though the Bacteroidetes and Firmicutes phyla dominate the gut microbiota, there are
some phyla present in smaller quantities that play a significant role in human health.
The Actinobacteria phylum composes ~3% of the gut microbiota25 and is dominated by
5

the Bifidobacterium genus.29 Bifidobacterium spp. are predominant in the infant gut
(90% of total microbiota), and their abundance declines to <5% in adults.29 This genus
contributes to gut health by producing lactate and acetate through carbohydrate
fermentation.29 Bifidobacterium ferment non-digestible carbohydrates including
resistant starch, pectin, inulin, cellulose as well as carbohydrates like mucin and human
milk oligosaccharides produced by the host.29 In addition, Bifidobacterium can produce
vitamin B12 and defensive bacteriocins.29 Other phyla represented in Figure 1 (i.e.
Proteobacteria; Fusobacteria; Verucomicrobia) will not be detailed as they are not phyla
and/or include genera that directly relate to the study objectives (objectives are
discussed in section 3.1).
2.1.2 Functions of the human gut microbiota
Through ongoing research, it is recognized that gut microbial communities function like
an organ that benefit both the host and the bacteria.30 Collectively, the functions of the
gut microbiota can be broken down into three categories: metabolism, biosynthesis,
and effect on the intestinal environment. As such, the gut microbiota are critical in the
daily functioning of the human body by degrading non-digestible food compounds,
synthesizing essential vitamins and SCFAs and assisting in producing metabolic endproducts.29 The microbiota also stimulate the host immune system to produce defensive
agents against harmful bacteria, and therefore maintain a favorable environment for
native commensal bacteria.31
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2.1.2.1 Colonic Metabolism
The gut microbiota play a significant role in the digestion and colonic metabolism of
food compounds, including dietary nutrients and phytochemicals. For example,
Bacteroides thetaiotamicron produces a collection of enzymes in a multi-step
degradation of carbohydrates.1 In addition, bacterial phytases can degrade phytic acid in
grains which release minerals including calcium, magnesium, and phosphate.1
Additionally, degradation of the polysaccharide and protein rich mucus layer allow
bacteria to meet their own energy needs while assisting in the turnover of the mucus
layer.1 Establishing a healthy mucus layer has been found to maintain endothelial
integrity, therefore, preventing potentially harmful gut conditions such as
endotoxemia.1
2.1.2.2 Bile acid metabolism
Bile acids are needed to facilitate the absorption of fat, cholesterol, and fat-soluble
vitamins from the intestine. The bile acids that do not recirculate to the liver are deconjugated by gut bacterial bile salt hydrolases (BSH), generating secondary bile acids.32
De-conjugation reactions including dihydroxylation, dehydrogenation, and
epimerization are performed by, but not limited to, the genera Bacteroides, Clostridium,
and Eubacterium.33 Recent literature has determined an association between bile salt
hydrolase activity and control of obesity and hypercholesterolemia. Joyce et al. found
that by elevating BSH, it reduced weight gain, serum cholesterol, and liver triglycerides
by directing expression of signaling pathways known for their role in lipid metabolism,
circadian rhythm, and epithelial cell function.34
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2.1.2.3 Biosynthesis
2.1.2.3.1 Vitamin production
A well-documented function of the gut microbiota is its role in the biosynthesis of
vitamins. Gut bacteria like Actinobacteria and Bacteroidetes can generate vitamin K and
B group vitamins including thiamin, biotin, cobalamin, niacin, pyridoxine, folate and
vitamin B1235. Intestinal production of several vitamins individually contributes to a
quarter or more of the suggested daily reference intake. For instance, production of
folate, niacin, pyridoxine, and cobalamin reach 37, 27, 86, and 31 percent of the
suggested dietary intake respectively.35 These vitamins participate in numerous
metabolic reactions throughout the body, with significant roles in blood clotting,
hematopoiesis, and tissue repair which maintain healthy nervous and cardiovascular
systems.36
2.1.2.3.2 Short Chain Fatty Acid production
One of the most physiologically important products of the gut microbiota are the SFCAs
produced by microbial fermentation of non-digestible dietary fiber.1 SCFAs provide
energy for colorectal tissues and bacteria and promote cellular mechanisms that
encourage tissue integrity.1 The SCFAs consist of acetate, butyrate, and propionate
which collectively contribute to host health through various processes.37
All three SCFAs can decrease pH in the colon which deters pathogen growth. Specifically,
acetate increases blood flow and oxygen uptake in the colon, acts as a co-substrate to
produce butyrate, and once absorbed, is an energy source for muscle and brain tissue.29
Propionate prevents proliferation of and induces apoptosis of colorectal cancer cells,
8

interacts with the host immune system, promotes satiety, lowers blood cholesterol
levels and improves insulin sensitivity.29 In a human study, inulin-propionate ester
significantly increased postprandial plasma PYY and GLP-1, and over the course of 24
days, propionate supplementation significantly reduced weight gain, intra-abdominal
adipose tissue distribution, and intrahepatocellular lipid content. Propionate also
prevented the decline in insulin sensitivity that was observed in the inulin-control
group.38 Epidemiological evidence also suggests that propionate can travel through the
circulatory system to impact immune function and inflammation in peripheral tissues
such as the lung.1 Lastly, butyrate stimulates the absorption of water and sodium in the
colon, reduces oxidative stress, prevents colon cancer and colitis, and improves gut
barrier function by stimulating mucin formation, antimicrobial peptides, and tightjunction proteins.29 These effects may reduce the likelihood of endotoxemia should any
pro-inflammatory substances leak across the gut barrier.39 Butyrate also acts to increase
host insulin sensitivity by stimulating the release of gastric inhibitory polypeptide from
enteroendocrine K-cells.39 Metabolically, both butyrate and propionate can regulate
energy intake, expenditure, and storage by stimulating the release of the satiety
hormones glucagon-like peptide 1 (GLP-1) and peptide YY from enteroendocrine L-cells,
therefore encouraging satiation.38,39
2.1.2.4 Effect on the intestinal environment
Another vital role of the gut microbiota is protecting against pathogen colonization and
maintaining a healthy gut environment.31 The microbiota achieve this homeostasis
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through competitive metabolic interaction, recruiting host immune responses, and
encouraging vascularization.
The gram negative and gram positive native commensal bacteria deter pathogen growth
by producing bacteriocins and proteinaceous toxins that inhibit members of the same
bacterial species. For instance, E. coli can produce bacteriocins when it needs to fend off
the related pathogen enterohaemorrhagic E. coli.31 Commensal bacteria and SCFAs can
also alter the pH of the gut environment to a level that prohibits pathogen colonization.1
This allows the commensal bacteria to occupy intestinal niches as colonization sites that
could otherwise be filled by pathogenic bacteria.31
Additionally, the commensal bacteria fend off pathogens and encourage epithelial
integrity by communicating with the host immune system. Since the lining of the gut is
the largest surface area in contact with exogenous antigens, the gut microbiota play a
central role in mucosal immunity and potentially preventing bacterial translocation.23
Research shows that the commensal bacteria promote epithelial barrier function by
synthesizing antimicrobial peptides resulting in fewer scenarios of pathogen
translocation.31 Over time, the presence of commensal bacteria may result in decreased
incidence of pathogen associated disease.
Research has also investigated the role of the intestinal bacteria in vascularization.
Stappenbeck et al. compared germ-free mice and B. thetaiotaomicron-colonized
transgenic mice with Paneth cells and found that the bacteria shaped the development
of the intestinal villus microvasculature through Paneth cell dependent interaction.40
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This study emphasizes how the gut microbiota may better promote absorption of
nutrients through increased vascularization.
2.1.3 Gut associated disease states
Through their many functions, gut bacteria have the capacity to help or harm the human
body. Small disturbances to their environment, and therefore the gut ecology, can result
in systemic complications for the human host. As such, dysbiosis and low diversity have
been associated with various disease states.2
The diversity of the gut microbiota has been associated with human health.41 A healthy
gut microbiota is characterized by high diversity with the ability to resist change under
stress, while lower species diversity and fewer beneficial microbes and/or presence of
pathobionts are associated with disease.2 Gut microbial diversity, measured via
intestinal biopsies or fecal samples, is the number and abundance of distinct types of
organisms found in the gastrointestinal tract and can be defined three ways.42 Alpha
diversity is the average species diversity in a habitat; beta diversity is the diversity of
species between two habitats; gamma diversity is the total diversity of a landscape, and
is the combination of alpha and beta diversity.43
Wong suggests that one advantage of having a greater microbial diversity could be to
guarantee that metabolic functions are unaffected by changes in gut composition,
whereby select microbes with similar functions can fill in for other microbes when a
certain metabolic task needs to be performed.41 Valdes et al. proposed that diversity is a
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good indicator of a ‘healthy gut’ in the sense that a diverse bacterial ecosystem will
compensate for missing species.44
When the composition of the gut microbiome is altered, such as a reduced diversity, a
state of dysbiosis is present, or an imbalance of helpful and harmful bacteria.44 Low
diversity can reduce resistance to pathogenic bacteria colonization, resulting in the
expansion of harmful bacteria.45 Low diversity may also limit production of SCFAs since
less bacteria of different types are available for fermentation.46 This dysbiosis may form
the basis for the pathogenesis of disorders such as atherosclerosis, IBS, diabetes, and
obesity.2 Notably, the imbalance of Firmicutes and Bacteroidetes has been a point of
interest in gut research as varying levels of their abundance is associated with several
disease states,47,48 namely obesity. The ratio of Firmicutes to Bacteroidetes in healthy
infants, adults, and elderly are reported to be 0.4, 10.9, and 0.6 respectively.49
Conversely, the F:B ratio varies among obese and lean individuals, with some studies
reporting an increased F:B ratio in obesity,48,50,51 while others report the opposite
relationship.52 Still, other studies have not found a correlation between BMI and the
reported F:B ratio.53 While the ratio of F:B has been quantified in healthy populations, a
taxonomic signature has yet to be established for unhealthy populations53 due to
interindividual variability from differences in diet, lifestyle, and other factors.
2.1.3.1 Atherosclerosis
Dysbiosis has been identified as a strong risk factor for atherosclerosis, specifically
through the production of trimethylamine-N-oxide (TMAO).22 TMAO inhibits reverse
cholesterol transport and is formed from trimethylamine (TMA) which is a product of
12

gut microbial degradation of dietary precursors like l-carnitine and
phosphatidylcholine.54 TMA is converted into TMAO in the liver by hepatic flavin
monooxygenase 3.55 The gut microbiota that are thought to be involved in the initial
conversion of l-carnitine and phosphatidylcholine to TMA include genera from the
Firmicutes and Proteobacteria phyla including Clostridium spp.,Escherichia fergusonii,
and Edwardsiella tarda.55 Furthermore, foods high in levels of l-carnitine and
phosphatidylcholine, such as cheese, seafood, eggs, and red meat, can accelerate the
development of atherosclerosis through microbial TMAO production.46 Gut microbiotamediated therapy has been proposed as one strategy to initiate inhibition of microbial
TMAO synthesis.22 In this way, the gut microbiota behaves as a potential preventive
agent of disease.
2.1.3.2 Type 1 and Type 2 Diabetes
The gut microbiota has also been implicated in other metabolic diseases, specifically
diabetes. A study by Larsen et al. compared the composition of the intestinal microbiota
in type 2 diabetics versus non-diabetics.47 The results found a significantly reduced
(p=0.03) abundance of Firmicutes in the diabetic group (36.8% mean) compared to
controls (56.4%), while Bacteroidetes was increased but not significantly in the diabetic
group.47 Similar results were captured in a study comparing children with type 1
diabetes to healthy children. The ratio of F:B in diabetic children (0.62) was significantly
lower (p=0.001) than in healthy children (0.97).56 Both studies found that the F:B ratio
correlated negatively and significantly to plasma glucose level and concluded that this
ratio could be implicated in the glycemic level of the diabetic individuals.
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2.1.3.3 Irritable Bowel Syndrome
Altered gut communities are also seen in irritable bowel syndrome (IBS). In a review,
Collins et al. discussed a variety of studies that repeatedly indicated an association
between IBS, bacterial dysbiosis, and altered ratios of bacteria species.57 For example,
when germ-free animals were colonized with fecal bacteria from patients with IBS
compared to healthy controls, it resulted in maintenance of IBS symptoms in the germfree animal. The microbial dysbiosis of the IBS gut microbiota (i.e. more sulfate-reducing
bacteria and less Bifidobacterium) along with hypersensitivity to colonic distension were
maintained.58 In addition, several studies have seen an increase in the phylum
Firmicutes and a decrease in the genus Bacteroides in IBS patients.57 Interestingly,
triggers such as infection, stress, and antibiotic use initiate dysbiosis, which can alter the
gut microbiota and may account for the characteristic symptoms of IBS over time.57
Presence of IBS has implications for overall health as the condition may impact
absorption of nutrients from the diet such that when the gut microbiota is disturbed,
the body may become less efficient at converting food to usable products.
2.1.3.4 Obesity
Alterations in the human gut microbiota has also been identified as a risk factor for
obesity, however, there is debate as to what capacity the gut microbiota contributes to
the pathophysiology of obesity. That is, does obesity result from changes in the gut
microbiota or does an obese status alter the gut microbiota? Nevertheless, several
mechanisms have been proposed to account for this observation: (1) increased energy
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harvested from the diet; (2) and changes in the intestinal barrier integrity linked to
lipopolysaccharide (LPS).3
In general, research indicates that there may be an association between the efficiency
of the gut microbiota to extract energy from the diet and the development of obesity.
Turnbaugh et. al. tested the mechanism behind this observation and found that when
an obese microbiota was colonized into germ-free mice, it resulted in a significantly
greater increase in total body fat.59 An increased concentration of butyrate and acetate
were also seen in the gut, which was accompanied by significantly less energy remaining
in their stools relative to the lean controls. Further, the obese microbiome had a
substantial increase in genes that encoded enzymes involved in the breakdown of
dietary polysaccharides.59 A suggested mechanism that linked the gut microbiota to this
observation included provision of additional energy via conversion of dietary fiber to
SCFAs.59
Further, a human energy balance study investigated how diets that varied in caloric
content impact the gut composition. Researchers found that alteration of the nutrient
load (2400 kcal to 3400 kcal) resulted in rapid changes in the gut microbiota. A 20%
increase in Firmicutes was associated with an increased energy harvest of ~150kcal and
a 20% increase in Bacteroides was associated with a decreased energy harvest of
~150kcal, suggesting the gut microbiota’s role in regulation of nutrient harvest.60
Another proposed mechanism that links the gut microbiota to obesity is the presence of
gut microbiota derived LPS.61 LPS is an inflammatory cell wall constituent of Gram-
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negative bacteria that, when released due to cell division or death, can trigger an
inflammatory cascade through Toll-like receptor-4 (TLR4), CD14, or NF-κB.37 Concerning
obesity, a hypothesis is that when LPS leaks into circulation, TLR4 activates proinflammatory pathways where cytokine expression induces altered metabolic function
in adipose tissue.62 Evidence of this interaction has been explored in animals and
humans. For example, infusion of LPS increased adipose tissue, insulinemia, and liver
insulin resistance in mice.62 Additionally, in women, intestinal permeability correlated
with visceral adiposity which was proposed to be related to LPS.63 Furthermore, a
positive correlation between serum LPS and BMI, high triglycerides, and central
adiposity was seen in young obese subjects.64 Together, these findings establish the
possible relationship between LPS and obesity. However, since there remain questions
relating the gut microbiota to health outcomes, it becomes increasingly more important
to assess how both non-modifiable and modifiable factors like diet can alter the gut
composition.
2.1.4 Factors that influence the gut microbiota composition
As previously mentioned, the gut microbiota seems to behave like a fluid ‘organ’ that
continuously adapts to its environment. As such, there are non-modifiable factors like
genetics, age, and hormones and modifiable factors like antibiotics, smoking, exercise,
and diet that contribute to its composition and associated functions.

16

2.1.4.1 Non-modifiable factors that influence the gut microbiota
2.1.4.1.1 Genetics
While there is intraindividual variability in microbial communities, the human
microbiota is generally stable at the phylum level with variation in phylum proportions
between individuals.23 As such, genetic factors can govern these individual differences
seen in the microbial populations. In a metagenomic study, researchers compared twin
pair microbiotas across 1,000 fecal samples from the TwinsUK population. The study
identified a variety of microbial taxa whose abundance was influenced by host
genetics,65 indicating a link between host genetics and the gut microbiota. Nevertheless,
the Bacteroidetes community was found to be shaped mostly by environmental
factors.65 This suggests that some bacterial species are not heritable and are likely
influenced by other factors.
2.1.4.1.2 Age
In addition to genetics, the composition of the microbiota changes with age (Figure 2).
Microbes begin to colonize the gut shortly after birth and the bacteria continue to
develop during breastfeeding as the oligosaccharides in breast milk encourage growth
of Lactobacillus and Bifidobacterium.1 Once the baby switches to whole foods, the
bacteria population shifts to favor bacteria that are needed to utilize fiber and other
nutrients present in adult diets like Bacteroidetes and Firmicutes.1 While a variety of
factors govern the composition of the gut microbiota–including genetics, puberty,
ovarian cycle, pregnancy, and menopause – age is independently associated with the
abundance of particular bacteria.1
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The gut microbiota of infants (3wk-10mo), adults (25-45yr), and older adult (70-90yr)
populations were sequenced with the following results: the infant gut microbiota was
dominated by Bifidobacterium (Actinobacteria phylum), the adult gut microbiota was
dominated by Firmicutes and Bacteroidetes, and the gut microbiota of older adults was
dominated by Bacteroidetes and Firmicutes with a significant presence of E. coli
compared to adults.49 The Bacteroides genus abundance was equivalent in all age
groups.49 Total bacteria count was significantly lower in infants than in adults and
seniors. Regarding the elderly population, the gut microbiota of 17 individuals from a
geriatric department showed that the proportion of Bacteroidetes was significantly
higher than in younger adults66 with similar findings reported by Claesson et al.67
Reasons for the shifts seen in dominant bacterial species are unclear, but living situation
(i.e. long-term care vs. community dwelling), altered diet,1 changes in digestive
physiology, and reduction in transit time and digestive secretions have been
postulated.49
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Figure 2. Gut microbiota composition across the lifespan, Ottman, 2012.68
2.1.4.1.3 Interaction between sex-related hormones and the gut microbiota
In addition to age, a person’s sex may influence the gut microbiota. Considering the agerelated decline in sex hormones in both men and women, researchers have investigated
the relationship between estrogen and the gut microbiota. Santos-Marcos et al.
analyzed the gut microbiota in 17 premenopausal and 20 postmenopausal women and
matched the two groups with men by age.7 Results showed a higher Firmicutes
abundance in postmenopausal women versus premenopausal women, with a higher F:B
ratio in postmenopausal women versus men. In addition, estradiol levels positively
correlated with various bacteria classes and families. Interestingly, the researchers
observed a lower relative abundance of SCFA producing bacteria, with lower butyrate
and propionate metabolism, in postmenopausal versus premenopausal women.7 This
has implications for women’s health as SCFAs have been associated with metabolic
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health. Teixeira et al. found that a higher level of fecal SCFA in women correlated with
metabolic syndrome risk factors with the authors suggesting that increased colonic
fermentation may contribute to obesity.69 However, SCFAs have also been shown to
regulate metabolic homeostasis through AMP-activated protein kinase70 while reducing
postprandial free fatty acids and increasing satiety hormones.71 Therefore, it is unclear
whether SCFAs contribute to metabolic risk or have the opposite effect by regulating
appetite and energy homeostasis. Nonetheless, the researchers concluded that the
differences in gut composition between men and women were influenced by hormonal
status in women, and these differences may influence incidence of metabolic disease
and their varied prevalence in men and women.7
Interestingly, not only has estrogen been associated with the gut microbiota, but recent
studies have shown that the gut microbiota is related to the development of CVD. 37
Research indicates that a transfer of fecal microbiota induces metabolic disease and
obesity.37 The literature also suggests that an association exists between metabolic risk
and gut microbiota changes in postmenopausal women.72 In one study, fecal DNA from
obese postmenopausal women were analyzed and a systematic search was performed
for bacterial genes associated with markers of insulin resistance, inflammation, and lipid
metabolism. Researchers found that 114 metagenomic species correlated positively or
negatively with the previously mentioned metabolic markers.72 The authors also found
that diet modulated beneficial bacteria and emphasized the importance of focusing on
diet when studying the link between gut microbiota and metabolic markers.
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As it relates to CVD risk in general, women tend to experience weight gain, particularly
in visceral adipose tissue, a few years prior to menopause,73 with postmenopausal
women experiencing greater intra-abdominal fat versus pre-menopausal women.74 This
physiological change coincides with losing 80% of their estrogen per year beginning the
first year of menopause4 which is accompanied by shifts in adipose tissue deposition
and expansion.74 Deposits of fat, especially in visceral adipose tissue, correlates to
increased circulating adipokines which are implicated in insulin resistance and CVD.73 As
such, women exhibit larger risk for metabolic disease as they age and with the transition
to postmenopausal status5 which is proposed to result from reductions in circulating
estrogen.6
As such, the association between estrogen and metabolic risk may be explained by its
interaction with the gut microbiota. The gut microbiota secretes β-glucuronidase which
convert estrogens to their deconjugated form.6 The estrogen then interacts with
estrogen receptors to elicit downstream effects resulting in physiological changes6 in the
uterus, ovaries, bone, breast, liver, muscle, white adipose tissue, and colon.75 In effect,
the gut microbiota encourages estrogen homeostasis. If gut dysbiosis and low gut
diversity occur, a reduction in estrogen metabolism is possible due to a lack of estrogen
metabolizing bacteria.6 Furthermore, a dysfunction in these physiological responses
could contribute to disease states including CVD, obesity, MetS, endometriosis,
polycystic ovary syndrome, and breast cancer.6 Proposed mechanisms for some of these
conditions include low gut microbiota diversity and low circulating estrogen levels.6

21

Of interest, phytoestrogens may be able to reduce the risk of developing some of these
conditions as they are a ligand for estrogen receptors.6 A recent article by Chen et al.
explained that the microbiota can metabolize estrogen-like compounds to their active
form, and these compounds can encourage proliferation of certain bacteria types.76
Phytoestrogenic foods, including soy and lignins, are also shown to improve weight gain
and are associated with a lower rate of overweight and obesity.76 Thus, phytoestrogens
may play a role in preventing MetS through gut transformation.
Furthermore, based on metagenomic analysis and the observed link between a decline
in estrogen levels and metabolic health, postmenopausal women appear to be at an
increased metabolic risk through both altered gut composition changes and the decline
in estrogen that may be exacerbated by dysbiosis. Additionally, since a sedentary
lifestyle, poor diet, and decreased mobility promote overweight and obesity, and
combined with decreased estrogen levels in postmenopausal women, this age groups
becomes a target for gut dysbiosis, MetS, diabetes, and CVD.
2.1.4.2 Modifiable
Of the factors that influence the gut microbiota, there are a few that may be modified.
Such factors include the use of medications, especially antibiotics, smoking, physical
activity level, and diet.
2.1.4.2.1 Antibiotics
It has been well established that although antibiotics are critical for killing harmful
bacteria, beneficial bacteria are often destroyed along with the harmful bacteria being
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targeted by the antibiotics. Use of antibiotics can suppress the commensal microbiota
community within the gut along with their resistance against pathogens. This provides
an opportunity for pathogenic bacteria to colonize the gastrointestinal tract. 31 One
deadly complication that can arise from antibiotic treatment is Clostridium difficile
associated diarrhea, resulting in decreased microbial diversity.23
2.1.4.2.2 Smoking
Smoking has also been found to alter the gut microbiota. Capurso et al. found that
smoking was associated with an increased rate of C. difficile infection while smoking
cessation correlated with increased microbial diversity.77 The authors note, however,
that confounders such as diet or an increase in body weight could have accounted for
these changes.77
2.1.4.2.3 Exercise
While antibiotics and smoking have been negatively associated with the composition of
the gut microbiota, evidence supports the positive role of exercise in gut health. In a
mouse model, Luo demonstrated that moderate exercise increased gene expression for
antimicrobial peptides accompanied by a lower degree of intestinal permeability and
bacterial translocation.78 Further, Mika et al. demonstrated that the onset of exercise
increased Bacteroidetes and decreased Firmicutes, a ratio associated with leanness.79
Interestingly, O’Sullivan et al. explains that the vagus nerve controls gastrointestinal
inflammation and exercise-induced activation of the nerve may encourage an antiinflammatory environment in the gut.80 Therefore exercise may influence the quantity
and quality of the gut microbiota composition.80
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2.1.4.2.4 Diet
The diet is among the most powerful influencers of the gut microbiota composition. The
following section will detail its impact on the gut microbiota.

2.2

Dietary Effects on the Gut Microbiota

Due to the diverse and variable diet of the average human, the gut microbiota must also
diversify to satisfy the body’s metabolic needs. As such, much of the microbial diversity
in the human gut is due to the microbial enzymatic capacity required to degrade
nutrients.1 For instance, adequate insoluble fiber and nitrogenous protein consumption
encourage bacterial fermentation in order to produce SCFAs.1 Additionally, dietary
intake appears to be a significant short- and long-term regulator of the composition of
the gut microbiota.81 However, only a small number of randomized controlled dietary
intervention trials have been conducted in humans, of which, diets rich in fiber, fruit,
and vegetables are associated with gut microbial activity that are linked to health
benefits including increased abundance of probiotic bacteria and decreased intestinal
inflammation.22 Thus, research seeks to isolate specific dietary patterns that increase
microbial diversity while discouraging dysbiosis.
2.2.1 Flexibility of the gut composition
Diet can selectively and quickly alter the gut microbiota composition within days. One of
the few studies in this area was by David et. al. who demonstrated how the gut
microbiota can be rapidly altered by diet.81 For five consecutive days each, participants
consumed two diets: a ‘plant-based diet’ rich in grains, legumes, fruits, and vegetables;
and an ‘animal-based diet’ rich in meats, eggs, and cheeses. The animal diet observed a
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significant increase in β-diversity after a single day but the gut microbiota reverted to
their original structure two days after the diet intervention ended.81 This study showed
that the human gut microbiota can rapidly switch between herbivorous and carnivorous
bacterial profiles in order to maximize nutrient utilization.
2.2.2 Diet-induced microbial diversity
Diversity has been associated with different diet patterns. For instance, individuals
consuming a plant-based diet versus a meat-based diet are shown to have a more
diverse fecal microbiota composition.1 In fact, the phylogenetic diversity seen in the
human gut is as follows: herbivore > omnivore > carnivore.82 Consuming a complex diet
may increase levels of different types of bacteria and therefore increase SCFA
production.46 With these considerations, if a diet-induced imbalance occurred, the
microbiota can adapt, and the host will be less susceptible to disease and more resilient
to stress.2
2.2.3 Diet-induced microbial dysbiosis
Normally, the gut microbial communities are in symbiosis with the host and perform
their physiological functions. However, diet can lead to microbial dysbiosis in the gut.
Diet-induced dysbiosis is associated with disturbed gut barrier functions, increased gut
permeability, and increased plasma LPS concentrations, leading to low-grade
inflammation that is associated with diseases such as obesity and MetS.29,62,83
Regarding diet-induced dysbiosis, consuming excess dietary fat is shown to expose the
body to potentially pro-inflammatory free fatty acids which can alter the gut
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composition and increase plasma LPS.61 Mice fed a high-fat diet saw increased plasma
LPS concentration by favoring the growth of certain Gram-negative bacteria resulting in
increased liberation of LPS.62 Dysbiosis from decimation of Firmicutes and Bacteroidetes
was associated with a disrupted intestinal barrier and LPS leakage across the gut wall
due to reduced tight junctions or carried with fat that was absorbed from the gut.62
2.2.4 Diet, Obesity, and the Firmicutes:Bacteroidetes ratio
As mentioned previously, the human gut microbiota is composed of 50-80% Firmicutes
and ~23% Bacteroidetes. An enlarged Firmicutes and reduced Bacteroidetes ratio (F:B)
seem to represent the ‘bacterial trademark’ that characterizes obesity.90 As such,
human and animal data support the theory that an increased ratio of Firmicutes to
Bacteroidetes may contribute to the pathophysiology of obesity.
At baseline, genetically obese mice are observed to have more Firmicutes than
Bacteroidetes compared to their lean counterparts.51 In order to support this
observation, as well as exclude that this ratio is restricted to genetically obese mice,
studies have characterized the gut microbiota of high-fat fed mice. Murphy et al. found
an increased Firmicutes and reduced Bacteroidetes proportion in mice fed a high fat
diet.50 Similar findings were observed in two other high-fat diet mice trials.91,92
In humans, adult female monozygotic and dizygotic twin pairs concordant for leanness
or obesity revealed that the obese gut microbiota was associated with significantly
lower Bacteroidetes and decreased diversity.93 This observation was analyzed in a diet
and weight loss study with obese individuals who were assigned to one of two low-
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calorie diets: fat or carbohydrate restricted.48 At baseline, obese people had fewer
Bacteroidetes (P<0.001) and more Firmicutes (P=0.002) than the lean controls. After
calorie restriction, and over time, Firmicutes decreased significantly (p=0.002) and
Bacteroidetes increased significantly (p<0.001) in obese participants. The results showed
that irrespective of which two diets were assigned, the lower F:B ratio correlated with
weight loss.48 This study indicates that certain bacteria may be implicated in obesity,
and that manipulating the gut communities could be one approach to addressing
obesity.
In addition to the observed variation in the F:B ratio due to calorie restriction, diet
pattern variations are shown to correlate with changes in the microbiota. For example, a
lower ratio of F:B was observed in children from rural Africa consuming a plant-based
dietary pattern versus European children consuming a western-style diet.87 The authors
speculated that this change may be a mechanism to maximize energy uptake from their
fiber-rich diet.87 This finding may explain why high fat diets in mice correlated with
higher Firmicutes, since the Bacteroidetes phylum specializes in fiber degradation.
While substantial evidence from robust studies support the association between the F:B
ratio and obesity, conflicting reports exist in the literature. Schwiertz et al. characterized
the fecal microbiota of overweight, obese, and lean adults and found that while the
total amount of SCFA was higher in the obese group, consistent with the obesity
hypothesis, they found a significantly higher abundance of Bacteroidetes than
Firmicutes in overweight and obese subjects compared to lean subjects.52 In addition,
one study found that the F:B ratio did not have a function in determining obesity, at
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least at the phylum level, between lean and obese individuals.94 Further, the obesity
associated Western diet83 has been shown to increase the Bacteroides genus within the
Bacteroidetes phylum,85 but evidence also shows that obese individuals have a higher
baseline F:B ratio.48
While research has found an association between the gut bacteria composition and
obesity, it is difficult to draw conclusions due to conflicting evidence. As such, the link
between obesity and the gut microbiota may be more complicated than a shift in the
Firmicutes:Bacteroidetes ratio. Therefore, since the link between the microbiota and
obesity is inconclusive, it may be beneficial to examine how dietary patterns as a whole
impact the gut to determine if an association persists across lifestyle factors.
2.2.5 Diet patterns
2.2.5.1 Western diet
The Western lifestyle is often characterized by high fat and high sugar consumption83
with a high incidence of chronic diseases including CVD and type II diabetes. Diet and
gut health studies have linked the Western diet to unfavorable changes in the gut
microbiota. In addition to the effects of high-fat diets already discussed, they can
increase microbial production of deoxycholic bile acid (DCA) concentrations,95 which is a
compound associated with liver cancer.96 Further, DCA was shown to significantly
increase Firmicutes while decreasing Bacteroidetes,96 similar to those observed in mice
fed high-fat diets. Diets high in saturated fat have also been found to increase numbers
of pro-inflammatory microbes like Bilophila wadsworthia.97 Additionally, fat in lard form
increased toll-like receptor activation and impaired insulin sensitivity versus
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consumption of fish oil in mice. The authors concluded that an interaction between gut
microbiota and the saturated fats led to these metabolic effects.86
2.2.5.2 Plant-Based
Compared to the western diet, plant-based diets are favored as they tend to produce
end products like SCFAs that assist in gut and overall health. Vegetarian and vegan diet
studies have substantiated the benefits of plant-based diets. In a pooled analysis of 5
cohort studies, mortality from coronary heart disease (CHD) was reduced 24% in
vegetarians compared with non-vegetarians.41 As such, plant-based diets may confer
health benefits through modulation of the gut microbiota. A greater abundance of
Bacteroidetes with a lower abundance of Firmicutes was observed when consuming a
plant-based diet versus consuming a typical western diet.87 Conversely, compared to a
Western diet, a Japanese diet (rich in soybean, radishes, cabbage, fish, seaweed and
green tea) resulted in lower counts of Bacteroides genera and higher counts of
Lactobacillus.98 Similar findings were observed in those following a vegetarian and vegan
diet versus an omnivore control diet–both intervention groups saw significantly lower
Bacteroides and Bifidobacterium counts, and vegans had significantly lower E. Coli and
Enterobacteriaceae counts.99 The discrepancy seen in these plant-based studies may be
explained by host genetics, different methodologies, or different microbiome profiling
techniques. Nonetheless, this data indicates that different diet patterns, specifically a
plant-based pattern, have the capacity to alter the gut microbiota which may or may not
be related to positive health outcomes like reduced CHD.
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2.2.5.3 Mediterranean
Evidence also reveals that the Mediterranean diet may confer benefits to the host by
altering the gut bacteria. As a diet that is plant-based, the Mediterranean diet is
encouraged as a healthy eating pattern to establish and maintain good heart health.100
Emphasis is placed on consuming high fiber, vegetables, fruit, grains, fish and poultry
and minimizing intake of red meat, dairy, and sweets. Further, saturated fat intake
should be limited in favor of monounsaturated fatty acids and polyunsaturated fatty
acids.100 One study found that vegan, vegetarian, and omnivore participants whose diets
aligned with the Mediterranean diet had increased fecal SCFAs, Firmicutes, and
Prevotella (Bacteroidetes phylum), while low adherence to the diet was associated with
elevated TMAO.101
2.2.5.4 Probiotics
Probiotics are live bacteria that, once consumed, benefit the host by colonizing the gut
and exerting health promoting functions. Probiotics are prescribed to aid in restoring
gut ecology in diseases such as IBS, IBD, enterocolitis, and infectious diarrhea.102 Various
Lactobacilli and Bifidobacterium strains are recognized as probiotic agents and are
thought to restore gut health.102 Their mechanisms vary depending on the strain of
bacteria and the disease in which it is used to treat, and include maintaining hostmicrobe interactions and pathogen growth, mucus secretion from goblet cells,
maintaining epithelial barrier integrity, and producing antibacterial factors including
activation of the host’s adaptive immune system.102 In a placebo-controlled randomized
controlled trial (RCT), 60 overweight healthy adults consumed probiotics with various
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strains of Bifidobacterium, Lactobacilli, and Streptococcus, which resulted in increases in
concentration of the same bacteria.103 Additionally, yogurt with probiotic strains of
bacteria reduced counts of enteropathogenic E. coli and Heliobacter pylori in-vitro.104
2.2.6 Fruit
Plant-based diets are shown to significantly alter the gut composition, and a large food
item consumed in a plant-based diet is fruit. Fruit is currently the second most popular
food item in the US, and by sales alone, berries, apples, bananas, grapes, and citrus rank
in the top five highest grossing fruits, with berry sales ranking the highest at $3.02
billion.105 Compared to other berries, strawberry consumption is much greater with an
estimated per capita annual consumption of 7.9 pounds per year.106 With increased
accessibility and per capita consumption, high levels of vitamins, minerals, and
antioxidants, fruit has the potential to be an effective approach to improving health,
specifically through the gut.
Gut health has been associated with the concept of the ‘three P’s which include
probiotics, prebiotics, and polyphenols.107 As such, research has investigated the effect
of berries and berry polyphenols on the gut as they have received attention as
antioxidants with properties to prevent chronic disease.108 The gut bacteria convert
polyphenols into active and bioavailable metabolites, suggesting that variations in the
gut microbiota can affect polyphenol activity108 and thus, may have short and long-term
impacts on human health.
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2.2.6.1 Previous work: polyphenols and gut health
While relatively low in polyphenols compared to strawberries, several studies have
assessed the potential for non-berry consumer fruits to modulate the gut microbiota.
Shinohara et al. found that consumption of two apples per day increased Lactobacillus
and Streptococcus while C. perfringens and Enterobacteriaceae decreased.13 Oranges
and bananas have also been identified as a fruit with the ability to beneficially alter the
gut microbiota. In a SHIME (Simulator of the Human Intestinal Microbial Ecosystem)
vessel, Duque et. al. found that fresh orange juice significantly increased commensal
bacteria species (from genera Lactobacillus, Enterococcus, Bifidobacterium, and
Clostridium) while reducing Enterobacteria.14 Mitsou et al. assessed the impact of
bananas on the gut microbiota and found that 60 days of banana consumption resulted
in a non-significant increase in Bifidobacterium levels in the banana group.15
In addition to whole non-berry fruit, two studies have investigated the influence of red
wine polyphenols on the human gut. Queipo-Ortuno et al. had 10 healthy men consume
272 ml a day of red wine (797.86 mg gallic acid equivalents [GAE] of total phenols), dealcoholized red wine (733.02 GAE of total phenols), or gin, each for 20 days.9 Red wine
polyphenols significantly increased Proteobacteria, Fusobacteria, Firmicutes, and
Bacteroidetes, while the de-alcoholized red wine increased Fusobacteria but
significantly decreased Firmicutes and Bacteroidetes. The authors concluded that red
wine polyphenols exhibit a prebiotic effect. Moreover, changes in cholesterol and Creactive protein concentrations were linked to changes in Bifidobacterium numbers.9
With the same diet supplement, but in participants with MetS, Moreno-Indias et al.
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found that red wine and de-alcoholized red wine, consumed for 30 days each,
significantly increased the number of Bifidobacterium and Lactobacillus while
decreasing Bacteroides, E. coli, and Enterobacter spp.10 The polyphenols also improved
various metabolic markers. The authors concluded that the changes in the MetS
participants’ gut microbiota could be responsible for the improvement in the MetS
markers.10
Polyphenols in the form of fruit extracts can also impact the gut microbiota. Molan et al.
assigned thirty healthy men and women to consume blackcurrant extract powder with
lactoferrin and lutein or to consume only blackcurrant extract powder in capsule form
four times per day for two weeks.11 Both forms of blackcurrant significantly increased
Bifidobacterium and Lactobacilli population sizes while Clostridium spp. and Bacteriodes
spp. decreased significantly. The authors concluded that blackcurrant powder can act as
a prebiotic.11 Similarly, in a controlled trial, Li et al. instructed 20 normal weight healthy
male and females to consume a daily dose of 1000 mg of pomegranate extract (680 mg
GAE of total phenols), equivalent to 8 oz of pomegranate juice, for 4 weeks.12
Consumption of pomegranate extract significantly increased Actinobacteria with a
significant decrease in Firmicutes. The authors proposed that these results may have
implications in weight maintenance and insulin resistance by changing the ratio of
Firmicutes to Bacteroidetes.12
Numerous studies have investigated the effect of whole berries on the composition of
the gut microbiota. Specifically, red berries have been analyzed in several controlled
diet intervention trials. Vendrame et al. investigated the daily consumption of a wild
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blueberry (WB) freeze-dried powder drink in a RCT, crossover, diet intervention.16
Twenty male volunteers with at least one risk factor for CVD consumed a 250 mL WB
drink (25g of WB freeze-dried powder; 375 mg anthocyanins) or a placebo drink for 6
weeks. Blueberry polyphenols significantly increased Bifidobacterium spp. after the
blueberry treatment with increased Lactobacillus acidophilus after both treatments.16
In another diet intervention, Ige et al. assigned four female volunteers to consume 600
ml of blueberry puree per day for 29 days.17 Before stool analysis, the samples were
incubated for Lactobacillus spp. and Enterobacteriaceae spp. The authors found that
consumption of blueberry puree resulted in new strains of Lactobacillus bacteria while
other Lactobacillus strains resisted the anti-oxidant properties of the blueberry.17
In addition to blueberries, raspberries have also been targeted as a fruit rich in
polyphenols with the potential to impart health benefits through the gut. In a free-living
diet intervention trial, Gill et al. instructed 10 male participants to consume 200 g of
raspberry puree (296 mg gallic acid equivalents) per day for 4 days.18 Following stool
sample analysis, it was observed that the raspberry supplementation resulted in small,
yet insignificant changes to the microbiota composition.18
In addition to assessing the impact of single fruits on the gut microbiota composition,
one researcher investigated the synergistic effect of a combination of whole red berries
on the gut. Puupponen-Pimia et al. assigned 32 male and female participants with MetS
to consume either 300 g of fresh berries (70.7 mg anthocyanins) comprised of 100 g
strawberry puree, 100 g frozen raspberries, and 100 g frozen cloudberries or to restrict
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berry consumption for 8 weeks.19 Participants maintained their habitual diet but
restricted consumption of berries to 80 g/day. Stool samples were collected during five
separate laboratory visits and were analyzed for microbial diversity. Results showed that
4 subjects in the berry group saw insignificant changes to their bacterial profile while 13
participants saw no change. Further, no significant differences in diversity of
predominant bacterial populations were seen between groups.19
Compared to the top fruits consumed in the US, as reviewed in the studies above,
berries, including strawberries, contain a wide spectrum of beneficial ingredients, and
combined with their affordability and accessibility, give them the potential to improve
health through the gut.

2.3

Strawberries

The strawberry (genus: Fragaria) is a member of the Rosaceae family and is widely
consumed in the Mediterranean diet due to their diverse nutritional composition.109
While researchers have just recently begun studying the health benefits of strawberries,
the strawberry dates back to the first century A.D. and have been eaten in small
quantities by people worldwide since ancient times.110 It wasn’t until the 1300s when
the French transplanted the wild strawberry into the garden that strawberries began to
be cultivated and widely consumed. The spread of this berry was slow and was not fully
appreciated until the end of the 18th century when the Chilean strawberry was crossed
with the Virginia strawberry, giving rise to the modern strawberry known today.110
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2.3.1 Biochemical composition
The unique biological composition of strawberries yields health benefits through their
high content of essential nutrients and beneficial phytochemicals. They exert their
effects on human health by impacting lipid profiles, insulin response, immunological
responses, and pathogen growth, and thus have implications for heart and gut health.109
The nutrients in strawberries that are likely to have the greatest impact on improving
human health are fiber, vitamin C (see appendix A for strawberry nutrient composition),
and various polyphenols, namely flavanoids, hydrolyzable tannins, and phenolic acids109
(Figure 3) (see appendix B for strawberry polyphenol composition). Briefly, as a
functional component of strawberries, fiber slows digestion and can control calorie
intake through satiation.111 Apart from their role in lowering LDL-CH, increasing insulin
sensitivity, and aiding in gut motility,112 fiber also improves gut health when degraded to
SCFAs. Vitamin C, a known antioxidant, participates in gene expression and is a cofactor
in enzymatic reactions throughout the body including collagen, carnitine, and
neuropeptide synthesis.113 Various cohort studies show that vitamin C is associated with
lower risk for hypertension, stroke, and coronary heart disease.113 The impact of
strawberry polyphenols on gut health are specific to each subgroup and will be
discussed individually in the following sections.
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Strawberry Polyphenols
Flavanoids

Anthocyanins

Hydrolyzable
Tannins

Phenolic
Acids

Ellagitannins

Hydroxycinnamic
Acids

Flavonols
Hydroxybenzoic
Acids

Flavanols

Figure 3. Main classes of strawberry polyphenols.
2.3.2 Effects on heart health
Recent literature has shown that strawberries exhibit beneficial effects on heart health.
While the mechanism is still unknown, strawberry polyphenols significantly lowered
triglycerides and oxidized LDL-CH (low density lipoprotein-cholesterol) after
hyperlipidemic adult men and women consumed a high-fat meal.114 Additionally,
strawberries have been found to significantly decrease total and LDL-CH in adult men
and women with MetS115 while significantly decreasing serum cholesterol levels in
overweight and obese men and women.116 In addition, strawberries appear to exert a
protective effect against the development and/or progression of inflammatory
conditions such as CVD. For instance, in various LPS treated cell models, including
mouse macrophages and human fibroblast cells, strawberries were shown to counteract
LPS induced oxidative stress by reducing ROS and nitrite levels; protecting against DNA
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damage and lipid and protein oxidation; and reducing pro-inflammatory cytokines (IL-1β
and IL-6) while increasing the anti-inflammatory cytokine IL-10.117,118
2.3.3 Effects on gut health
As a rich source of polyphenols, another way strawberries impart their health benefits is
through modulation of the gut microbiota. Polyphenols undergo metabolism by the gut
microbiota therefore producing metabolites that are more readily available to the
body.107 Colonic fermentation of polyphenols yield numerous absorbable
biotransformation products including phenylacetic, phenylpropionic, phenylbutiric,
valeric acids, valerolactone, and urolithin A and B.119
Once ingested, polyphenols have been shown to promote the growth of bacteria
including Lactobacillus and Bifidobacterium.107 In this way, polyphenols exhibit prebiotic
like effects and can be viewed as relevant modulators of beneficial microbiota. 108 Such
effects have been documented in a variety of in-vitro and clinical studies with
polyphenol-rich foods, many of which have been detailed in the above text [Section
2.2.2]. Further, recent studies have shown a positive association between consuming
polyphenol-rich foods and a lower F:B ratio.90,120,121
2.3.4 Phytochemicals
As previously mentioned, strawberries derive some of their health benefits from
nutritive compounds. Strawberries also consist of nonnutritive phytochemical
compounds that impart their benefits through the gut. Phytochemicals are plant
metabolites that enable the plant to overcome environmental threats while controlling
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growth and reproduction.122 Such effects have prompted researchers to identify
phytochemicals with therapeutic potential in humans, including those found in
strawberries. The major phytochemicals present in strawberries include anthocyanins,
flavonols, flavanols, ellagitannins, and hydroxycinnamic/hydrobenzoic acids.111
2.3.4.1 Anthocyanins
Anthocyanins represent a major phytochemical group in strawberries with more than 25
different anthocyanin pigments reported including pelargonidins and cyanidins.109 A
meta-analysis by Giampieri et al. details the health benefits of strawberries and explains
that anthocyanins avoid absorption in the small intestine and subsequently pass
through to the colon where bacteria convert the chemical into smaller phenolic acids. 123
Regarding their impact on human health, one study found that anthocyanins exerted an
anti-inflammatory effect in human epithelial cells infected with Heliobacter pylori
thereby ameliorated gastric mucosal damage.124 Another study found that one month of
consuming 500 g of strawberries in healthy individuals was associated with
improvement of the serum lipid profile.125 Therefore, the intake of anthocyanin-rich
strawberries could potentially prevent gastrointestinal distress and the pathogenesis
CVD.
2.3.4.2 Flavonols
Another bioactive compound in strawberries are flavonols which consists of quercetin
and kaempferol compounds.111 Members of the flavonoid class are primarily degraded
by Clostridium and Eubacterium.119 Quercetin has been shown to exhibit prebiotic and
anti-microbial potential by stimulating Lactobacillus spp. growth and inhibiting E. coli119
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while enhancing the intestinal barrier function.126 Research also reported the ability of
quercetin to attenuate the increase in the F:B ratio in high-fat fed mice.90
2.3.4.3 Flavanols
Flavanols consist of compounds including catechins and proanthocyanidins.111
Proanthocyanidins are found in the strawberry flesh111 and, like anthocyanins, are
processed by the gut bacteria to produce phenolic acids.123 In a double-blind crossover
RCT, cocoa flavanols increased Bifidobacterium and Lactobacilli populations and
decreased Clostridia counts.127 Like flavonols, flavanols may also impart health benefits
through prebiotic activity.
2.3.4.4 Hydrocinnamic/Hydrobenzoic acids
Hydroxycinnamic hydroxybenzoic acids exist within the phenolic acid group and include
caffeic acid, gallic acid, and coumaric acid.109 Of the available research, hydrocaffeic acid
has been shown to exhibit anti-inflammatory activity in vitro and in vivo, eluding to their
anti-cancer properties.128
2.3.4.5 Ellagitannins
Hydrolyzable tannins represent the second major phenolic class in strawberries. Within
this class, ellagitannins are the only major group.111 Ellagitannins are comprised of
various compounds including ellagitannin, ellagic acid, ellagic acid glycosides, sanguiin
H-6, and galloyl-bis-HHDP-glucose.109 Ellagitannins are only found in cloudberry,
raspberry, rose hip, sea buckthorn, and strawberry. Notably, strawberries exhibit
antimicrobial properties through the activity of ellagitannins.109 An in-vitro study found
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that phenolic extracts from strawberries elicited antimicrobial activity against B. cereus,
H. pylori, C. jejuni, and C. albicans, thereby revealing that ellagitannins are principally
involved in pathogen suppression.109
Of specific interest, the gut microbiota can convert ellagic acid into bioavailable
urolithins; a class of compounds shown to exhibit anti-inflammatory and
anticarcinogenic effects.129 The bacteria Gordonibacter urolithinfaciens and other
unknown species are involved in the conversion of ellagic acid to urolithin A, isourolithin
A, and urolithin B.107 Urolithins are produced in various concentrations depending on
the individual which may have implications for health.129 In a study looking at microbial
metabolism of ellagic acid, three different urolithin phenotypes were consistently
observed in human intervention trials: ‘Phenotype A: produce only urolithin A’,
‘Phenotype B: produce isourolithin A and/or urolithin B in addition to urolithin A’, and
‘Phenotype 0: no detections of urolithins’.129 These observations were made
independent of age, gender, BMI, health status, or amount and type of ellagitannin food
ingested. However, phenotype B was observed in individuals with MetS or colorectal
cancer associated with dysbiosis.129 Based on these data, the gut microbiota
composition may modulate urolithin production and bioavailability, therefore targeting
the gut may be beneficial when considering the health benefits of ellagic acid.

2.4

Conclusion

Due to their popularity, accessibility, and high polyphenol content compared to other
popular consumer fruits, strawberries have recently emerged as a functional food which
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are implicated in disease prevention and health promotion.109 Specifically, the phenolic
compounds found in strawberries stimulate the growth of commensal and probiotic
strains of bacteria,8 and thus, may be an alternative to pharmaceutical interventions for
improving gut health. Furthermore, recent research has linked the gut to a variety of
cardiometabolic disease states, and thus, diet modification may be one method to
promote health through modulating the gut bacteria.
To date, research has not assessed the potential effect of a daily, modest consumption
of strawberries (~1 cup/d) on the gut microbiota in overweight, postmenopausal
women. Research has shown that CVD risk increases in women with age and the
transition through menopause.5 Since research has shown a significant relationship
between diet, the gut microbiota, and risk factors for cardiovascular and metabolic
disease,2 targeted dietary interventions may be effective at improving cardiometabolic
health in postmenopausal women through the gut. Therefore, to add to the body of
research, and reduce the gap in the literature, the aim of this study is to evaluate the
effects of strawberry consumption on gut health in postmenopausal women.
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3. MATERIALS AND METHODS
3.1

Objectives

Given the potential role of strawberries on gut health, and the association between gut
bacteria and health outcomes, the objectives of this study were to determine the impact
of daily strawberry consumption on specific gut health changes in overweight,
postmenopausal women. Specifically, we identified if 13 g/d of FDSP would impact the
following objectives:
•

Objective #1: Firmicutes to Bacteroidetes ratio.

•

Objective #2: Bacterial diversity.

•

Objective #3: Relative abundance of Lactobacillus and Bifidobacterium.

These objectives were based on the hypothesis that polyphenol intake may modulate
the gut microbiota by influencing the growth of specific bacteria linked to host health.
Therefore, the hypothesis is that daily consumption of FDSP, equivalent to 1 cup of fresh
strawberries, will beneficially affect the composition of the gut microbiota by reducing
the ratio of Firmicutes to Bacteroidetes, increasing microbial -diversity, and increasing
the relative abundance of probiotic Lactobacillus and Bifidobacterium bacteria.

3.2

Participants and Recruitment

Participants were recruited from San Luis Obispo and Fresno counties through flyers,
digital, and social media advertisements. Ten weight-stable (≤5% body weight change in
previous 6mo), overweight (BMI 25-34.9 kg/m2), postmenopausal women (age ~45-70y;
>12mo since last menstrual cycle) volunteered to participate in this study (Figure 5).
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Participants were generally healthy and had not altered their physical activity levels for
at least 6 months prior to the start of the study. Exclusion criteria included:
1. Smoking or tobacco use (current or within the past 6 months);
2. >7 alcoholic beverages/wk OR > 2 servings/day (beverage = 12 oz. beer, 5 oz.
wine, 1.5 oz. distilled spirits);
3. Currently following an energy-restricted (intentionally reducing energy intake to
lose weight) or low-fat (<20% energy from fat) diet;
4. Regular physical activity level >180min/wk of moderate to high intensity physical
activity, excluding activities normally required for participant’s occupation;
5. Planning to begin engaging in moderate to high intensity physical activity
>90min/wk after being sedentary for >6 months;
6. Use of medications or supplements that could interfere with the outcomes of
this study (including probiotics and antibiotics);
7. Unwilling or unable to consume <5 serv/wk of soy (specifically tofu and
soybeans), green tea, or high-cocoa (>60%) dark chocolate, combined;
8. Unwilling or unable to avoid consuming more than 1 serving of red wine per
week;
9. Allergic to strawberries.

3.3

Screening

Volunteers were screened through a two-step process: 1. Completion of an online or
phone eligibility questionnaire and 2. In person verification of BMI. The study website
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was hosted on Cal Poly’s Drupal Secure Forms website which included a link to a page
with the eligibility screening questionnaire. If the volunteers were eligible based on the
screening questionnaire, they were invited to come to the Cal Poly Human Nutrition Lab
for an in-person screening to verify BMI. Following the in-person screening, eligible and
interested individuals were asked to read and complete the informed consent form and
complete a health history questionnaire in order to participate in the study.

3.4

Experimental Design

This study was a 5-week free-living diet intervention trial consisting of a 3-week
washout (Figure 4) followed by a 2-week diet intervention treatment.

Screening
Invited to
participate

Washout

Supplement
Intervention

3 weeks

2 weeks

Health Check

Participation
ends

Health Check

Figure 4. Study flow diagram.

3.5

Intervention

3.5.1 Washout
Once informed consent was obtained, each participant completed a 3-week washout
phase which required the participant to avoid consuming dietary sources high in
polyphenols and probiotics, including, but not limited to foods or beverages with fresh,
frozen, or processed berries. Participants were also asked to consume ≤5 servings per
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week of tofu, soybeans, green tea, and high-cocoa chocolate. A list of foods to avoid was
given to participants to reference for the duration of the study (see appendix C).
3.5.2 Health Check #1 and #2
After the participants successfully completed the washout, they proceeded to the first
Health Check. “Health Check #1” was a baseline set of assessments including
anthropometrics, two fecal collections, and 3-day diet and physical activity records.
After the washout, participants began the intervention and then ended the study with
“Health Check #2”. The same health check assessments that were performed in Health
Check #1 were performed during Health Check#2.
3.5.3 Supplement intervention
For 2-weeks during the supplement intervention, participants consumed 13 g/d of FDSP,
equivalent to ~125 g fresh strawberries (~1 cup fresh), in 4-8 oz of water every day. To
ensure palatability, participants were given the option to mix into a smoothie form with
banana, orange juice, or ice (one participant mixed strawberry powder with almond
milk). The supplement composition is as follows:
Freeze-dried strawberry powder – 13 g FDSP; composed of dehydrated strawberries
representing a mixture of cultivars commonly available to consumers in the United
States as fresh and frozen berries (See Appendix A and B for nutrient composition and
polyphenol composition of FDSP).
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3.6

Assessment Procedures

A brief schedule of assessments completed by the participants is shown below (Table 1).
A week-by-week breakdown of the study activities was given to participants along with
a calendar that depicted when to collect the stool samples and when to complete the 3day weighted diet and physical activity records.
Table 1. Assessments.
Study Phase

Assessment Time
Point (Wk)

Assessments*

Screening

0

Anthropometrics, Health
History Questionnaire

Washout

3

Anthropometrics, Gut
Microbiota, Diet & PA

Supplement
Intervention

5

Anthropometrics, Gut
Microbiota, Diet & PA

*PA=Physical activity
This study was approved by Cal Poly Institutional Review Board (IRB#2018-277-CP).
3.6.1 Anthropometrics
Both body weight and height were assessed at baseline. Weight was determined using a
Seca scale (seca 876, Seca GmbH & Co. KG, Hamburg, Germany). Height was determined
using a Seca stadiometer (seca 217, Seca GmbH & Co. KG, Hamburg, Germany). Body
weight was assessed after the 3-week washout and following the 2-week intervention
period. BMI was calculated from weight and height.
3.6.2 Diet, Physical Activity, & Health History
Diet, PA, and health history was assessed at baseline using a Health History
Questionnaire. Three-day weighed food and PA records (see Appendix D and E) were
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used to document, track, and assess dietary intake and PA and were performed within
the week before each health check. Participants used a tracking log to document berries
and other foods high in probiotic and polyphenolic that may have been consumed
throughout the study. Diet and PA data were analyzed using ESHA Food Processor
(v10.14.2).
3.6.3 Gut Microbiota Health - Fecal Analysis
Following the washout and supplement intervention, participants provided 2 fecal
samples over a 4-7 day period during the last week of the washout phase and within the
two days following the end of the supplement intervention. Participants were provided
with uBiome’s stool Gut ExplorerTM collection kit (Figure 5) that included instructions
and return procedures along with all necessary supplies. All participants were given
gloves to reduce the risk of fecal contamination. The kit is equipped with the following
materials: a collection vial, swabs, a replacement vial, a sample return bag in which the
sample is placed before putting in the return mailer, and a return mailer (with prepaid
postage by uBiome). All participants collected their stool samples according to protocol
outlined in the kit. Briefly, following a bowel movement, participants were instructed to
use a sterile swab to transfer a small amount of fecal material into a vial containing a
proprietary lysis and stabilization buffer that preserves the DNA for transport to the
uBiome research facility at ambient temperatures130. Participants obtained the stool
sample by wiping the swab to the soiled toilet paper and then swirled the swab in the
vial for one minute. After collection, participants mailed their de-identified samples to
the uBiome research facility for DNA extraction and 16S rRNA gene sequencing.
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Figure 5. uBiome ExplorerTM gut kit.
3.6.4 DNA extraction and 16S rRNA Gene Sequencing
According to uBiome protocol, samples were lysed using bead-beating, and microbial
DNA was extracted in a class 1000 clean room by a guanidine thiocyanate silica columnbased approach using a liquid-handling robot. Polymerase chain reaction (PCR)
amplification of the 16S rRNA genes was performed using universal V4 primers (515F:
GTGCCAGCMGCCGCGGTAA and 806R: GGACTACHVGGGTWTCTAAT). Samples were
barcoded with a unique combination of forward and reverse indexes allowing for
simultaneous processing of multiple samples. PCR products were pooled, columnpurified, and size-selected through microfluidic DNA fractionation. Consolidated
libraries were quantified by quantitative real-time PCR using the Kapa Bio-Rad iCycler
qPCR kit on a BioRad MyiQ before loading into the sequencer. Sequencing was
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performed in a pair-end modality on the Illumina NextSeq 500 platform rendering 2 x
150 bp pair-end sequences.130

3.7

Compensation

Upon completion of all study requirements, participants were compensated with a $50
gift card to Target or Amazon based on their preference.
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4. RESULTS
4.1

Participants

A total of 31 participants completed the online screening questionnaire, 12 of whom
qualified for the study based on the questionnaire (Figure 6). At California Polytechnic
State University-SLO, 5 participants were screened to confirm their final eligibility, and
each qualified. At the Eye Medical Center of Fresno, 7 participants were screened to
confirm their final eligibility, and each qualified. Of the 12 total participants who
qualified, 10 completed the study: 4 from San Luis Obispo (SLO) and 6 from Fresno.
Reasons for participant drop-out included health concerns and stomach discomfort from
the supplement.
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Enrollment
Completed questionnaire (n=31)
Screened for eligibility (n= 12)

Excluded (n= 0)
• Not meeting inclusion criteria
(n= 0)
• Declined to participate (n= 0)
• Other reasons (n= 0)

Intervention
Began intervention (n= 12)
• Received allocated intervention
(n=11)
• Did not receive allocated intervention
(n=1) (due to health concerns)

Follow-Up
Lost to follow-up (n=0)
Discontinued intervention before end of study (n=2)
• 1=early withdrawal due to health concerns
• 1=early withdrawal due to intolerance to FDSP

Analysis
Analysed (n= 10)
• Excluded from analysis (n=2)
o 2=did not complete intervention

Figure 6. Consort flow diagram of participant participation.
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Baseline characteristics are shown in Table 2. None of the characteristics were
significantly different between participants from SLO or Fresno.
Table 2. Participant baseline characteristics, mean ± SD.
Characteristic
SLO (n=4)
Age, years
59 ± 6.27
Body weight (kg)
75.9 ± 9.98
2
BMI (kg/m )
31.7 ± 4.05
SLO=San Luis Obispo
BMI=Body Mass Index

4.2

Fresno (n=6)
61.5 ± 11.11
73.91 ± 11.88
28.83 ± 3.03

Mean (n=10)
60.5 ± 9.13
74.71 ± 10.61
29.98 ± 3.58

P-value
0.70
0.79
0.23

Measures of Adiposity

Results for body weight and BMI among all 10 participants are shown in Table 3.
Table 3. Measures of adiposity at baseline, week 3, and week 5, (n=10).
Measure of
Adipositya

Baselineb

Week 3b

Body weight (kg)
74.71 (3.30) 74.15 (3.30)
2
BMI (kg/m )
29.98 (1.11) 29.76 (1.11)
aParticipants were categorized as a random effect
bLeast squares mean (standard error of the mean)
BMI=Body Mass Index

Week 5b
74.39 (3.30)
29.80 (1.11)

P-value
0.22
0.26

There were no significant differences in body weight between baseline and subsequent
weeks. Average body weight at baseline was 74.71 kg and was 74.15 kg and 74.39 kg on
week 3 and week 5 respectively.
Similarly, there were no significant differences in BMI between baseline and subsequent
health checks. Average BMI at baseline was 29.98 kg/m2 and was 29.76 kg/m2 and 29.80
kg/m2 at the end of week 3 and week 5 respectively.
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4.3

3-Day Diet Record

Results from the 3-Day Diet records including calorie count and macronutrient and
micronutrient intake are show in Tables 4-7 below.
Table 4. Calorie count and macronutrient intake, (n=10).
Nutrient
Week 3a
Week 5a
Calories (kcal)
1634.39 (148.82)
1618.02 (145.65)
CHO (g)
202.83 (20.54)
205.31 (15.40)
Protein (g)
57.48 (5.38)
60.37 (7.38)
Fat (g)
68.34 (6.39)
63.11 (8.23)
Fiber (g)
20.92 (2.16)
19.14 (1.93)
Fiber (per 1000 kcal)
13.01 (0.93)
12.11 (1.12)
Sugar (g)
66.02 (6.72)
80.49 (7.51)
aLeast squares mean (standard error of the mean)
bSignificant value (p≤0.05)
CHO=Carbohydrate

P-value
0.78
0.84
0.48
0.28
0.34
0.54
0.03b

There were no significant differences in calories, carbohydrates, protein, fat, or fiber
between week 3 and week 5. There was a significant difference in sugar intake between
week 3 and week 5 (p=0.03). Sugar intake at the end of week 3 was 66.02 (6.72) g while
at the end of week 5 increased to 80.49 (7.51) g. Sugar intake was not significant
(p=0.27) when the sugar from the FDSP (7.96 g) was removed from the analysis.
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Figure 7. Participant calorie, CHO, protein, and fat intake at week 3 and week 5.
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Fiber (per 1000 kcal)
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Figure 8. Participant fiber and sugar intake at week 3 and week 5.
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The calorie count and macronutrient intake varies between participants from week 3 to
week 5 (Figure 7 and 8).
Table 5. Vitamin intake, (n=10).
Vitamin
Week 3a
Week 5a
A-RAE (μg)
464.49 (66.61)
471.76 (65.38)
D (μg)
1.91 (0.38)
2.45 (0.45)
E (mg)
8.01 (2.55)
6.39 (0.99)
K (μg)
85.38 (22.95)
47.84 (14.19)
B1 (mg)
0.97 (0.22)
0.92 (0.20)
B2 (mg)
1.26 (0.18)
1.33 (0.20)
B3 (mg)
12.02 (1.77)
13.70 (2.66)
B5 (mg)
3.11 (0.34)
2.70 (0.44)
B6 (mg)
1.07 (0.16)
1.19 (0.20)
Biotin (B7) (μg)
12.16 (3.68)
7.76 (2.54)
Folate (B9) (μg)
300.13 (55.16)
263.73 (38.73)
B12 (μg)
1.79 (0.30)
3.04 (0.56)
C (mg)
84.83 (18.23)
106.22 (11.39)
aLeast squares mean (standard error of the mean)
bSignificant value (p≤0.05)

P-value
0.94
0.19
0.40
0.20
0.43
0.46
0.33
0.39
0.33
0.13
0.36
0.03b
0.36

There were no significant differences in any vitamin except for vitamin B12 (p=0.03).
The average vitamin B12 intake at the end of week 3 was 1.79 (0.30) μg and was 3.04
(0.56) μg at the end of week 5.
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Table 6. Mineral intake, (n=10).
Mineral
Week 3a
Week 5a
Calcium (mg)
625.02 (93.66)
641.46 (104.92)
Chromium (μg)
0.59 (0.21)
1.04 (0.37)
Copper (mg)
0.91 (0.22)
0.63 (0.11)
Fluoride (mg)
1.52 (0.56)
1.02 (0.29)
Iodine (mcg)
38.33 (8.66)
34.25 (9.94)
Iron (mg)
12.30 (3.03)
12.61 (3.01)
Magnesium (mg)
226.71 (47.02)
180.45 (26.18)
Manganese (mg)
2.25 (0.95)
1.33 (0.27)
Molybdenum (mg)
15.36 (6.44)
7.67 (2.84)
Phosphorus (mg)
805.94 (157.82)
734.79 (123.41)
Potassium (mg)
1772.9 (163.31)
1696.42 (148.07)
Selenium (μg)
50.89 (9.23)
45.08 (6.37)
Sodium (mg)
2165.8 (271.40)
2193.65 (274.56)
Zinc (mg)
6.13 (1.22)
6.28 (1.04)
aLeast squares mean (standard error of the mean)

P-value
0.72
0.12
0.08
0.46
0.35
0.71
0.19
0.27
0.11
0.51
0.69
0.47
0.89
0.82

There were no significant differences in mineral intake between week 3 and week 5.
Results for fruit and vegetable intake are shown in Table 7 below.
Table 7. Fruit and vegetable intake, (n=10).
Food Group
Week 3a
Week 5a
Fruit (cup equivalent)
0.87 (0.21)
2.09 (0.28)
Vegetable (cup equivalent) 1.56 (0.32)
1.22 (0.27)
aLeast squares mean (standard error of the mean)
bSignificant value (p≤0.05)

P-value
0.0014b
0.43

There was a significant difference in fruit intake (p=0.0014) between week 3 and week
5. Fruit intake was not significant (p=0.24) when the 1 serving of fruit from the FDSP was
removed from the analysis. There was no significant difference in vegetable intake
between week 3 and week 5.
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4.4

Gut Health

Strawberry consumption did not result in a significant change to the F:B ratio or diversity. Likewise, Bifidobacterium and Lactobacillus abundance did not significantly
change.
4.4.1 Bacteria abundance and alpha diversity
Table 8 and the following graphs (Figure 8-10) depict changes in Firmicutes,
Bacteroidetes, Bifidobacterium, Lactobacillus, and -diversity between week 3 and
week 5.
Table 8. Bacteria abundance and alpha diversity, (n=10).
Bacteria
Week 3a
Week 5a
Firmicutes
49.67% (2.72)
51.58% (3.03)
Bacteroidetes
35.18% (2.11)
38.34% (2.45)
Bifidobacterium
0.50% (0.19)
0.68% (0.27)
Lactobacillus
0.16% (0.13)
0.47% (0.45)
-Diversity
1.83% (0.07)
1.78% (0.09)
aLeast squares mean (standard error of the mean)
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P-value
0.97
0.09
0.24
0.18
0.81

Figure 9. Abundance of Firmicutes and Bacteroidetes at week 3 and week 5.
There was a non-significant increase in Firmicutes and Bacteroidetes between week 3
and week 5.
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Figure 10. Abundance of Bifidobacterium and Lactobacillus at week 3 and week 5.
There was a non-significant increase in Bifidobacterium and Lactobacillus between week
3 and week 5.
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Figure 11. Alpha diversity at week 3 and week 5.
There was a non-significant decrease in -diversity between week 3 and week 5.

4.5

Statistical methods

Statistical analysis was performed on a personal computer with JMP software (SAS
Institute Inc., Cary, NC). Analysis of variance was used to evaluate variance in both body
weight and BMI between baseline and the two health checks. Paired t-test was used to
evaluate any variance in calories, macronutrients, vitamins, and minerals consumed by
the participants between week 3 and week 5. Paired t-test was used to evaluate diversity and relative abundance of the different bacterial groups between week 3 and
week 5. In all statistical tests performed, P values of ≤0.05 were considered significant.
Analysis of anthropometrics, 3-day diet records, and bacterial abundance and diversity
were performed on 10 participants.
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5. DISCUSSION
The present study assessed the effect of strawberries (13 g FDSP/d) on gut health in a 5week diet intervention trial with one treatment group. Strawberry consumption was not
associated with significant changes in measures of adiposity (i.e. body weight, BMI) or
changes in diet (i.e. macronutrients, vitamins, minerals) except for sugar, vitamin B12,
and fruit consumption. There were no significant differences in -diversity or any
bacteria phyla or genera. The data suggests that strawberry consumption at 13 g/d FDSP
does not result in significant changes to obesity-associated gut microbiota or beneficial
bacteria genera.
The current research is unique compared to previous research for several reasons. The
population was composed of postmenopausal women, a population that is strikingly
underrepresented in nutrition research. Postmenopausal women were selected as the
study population as they are a target for gut dysbiosis and exhibit increased CVD risk. As
previously discussed, studies show that polyphenol rich fruits like strawberries may
ameliorate dysbiosis and decrease CVD risk. In addition, to our knowledge, three
studies131-133 have investigated diet and gut health in postmenopausal women, while no
study has assessed the effect of strawberries and gut health in postmenopausal women.
One strawberry diet intervention study analyzed the combined effect of strawberry
puree, raspberries, and cloudberries on gut health,19 however, the population was not
comprised of postmenopausal women and the intervention material was not strictly
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strawberries. Furthermore, this is the first study to evaluate the effect of strawberries
on gut health in postmenopausal women.

5.1

Measures of Adiposity

Participants did not exhibit significant differences in any measure of adiposity from
baseline to week 5, nor were any significant differences seen between population
groups. While no previous research has evaluated the effect of strawberry consumption
on body weight or BMI in postmenopausal women, these findings are consistent with
other gut health diet interventions. In a 6-wk RCT evaluating probiotic strains and fiber
on gut composition in overweight postmenopausal women, there were no significant
differences in anthropometric measures compared with placebo.132 Similarly, in a red
wine polyphenol gut health study, researchers did not observe a significant difference in
weight from baseline to end of intervention.9 Likewise, a 4-wk RCT assessing cocoaderived flavanols on gut health found no significant change in BMI.127 Weight loss or
gain was not anticipated for the current research and the data reflects this.

5.2

3-Day Diet Records

This study was supplementary in nature and therefore did not include a controlled diet
regimen; however, in the course of 5-weeks, participants did not show any significant
differences in macronutrients, vitamins, or minerals except for sugar (g), vitamin B12
(μg), and fruit consumption. Fruit consumption increased, but upon further analysis, the
1 serv/d fruit from the FDSP accounted for the significant increase in fruit consumption.
Therefore, it may be the case that any changes in the gut microbiota, while statistically
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insignificant, were a response to strawberry supplementation. Likewise, the relatively
high sugar content of 13 g FDSP explained the significant increase in sugar intake
between week 3 and week 5. This reveals that strawberry intake significantly
contributed to overall sugar consumption.

5.3

Gut Microbiota

Following strawberry supplementation, participants did not show a significant change in
bacteria abundance (i.e. Firmicutes, Bacteroidetes, Bifidobacterium, Lactobacillus) or diversity. Our hypothesis was that we would see a decrease in Firmicutes and/or an
increase in Bacteroidetes (leading to a decrease in F:B ratio), an increase in
Bifidobacterium and Lactobacillus, and that there would be an increase in -diversity
following diet intervention. However, at the end of the study, there was no statistically
significant change in any of these three objectives.
Previous research of similar study design and duration also did not detect significant
changes in the relative abundance of gut microbiota as demonstrated by raspberry
puree supplementation18 and supplementation consisting of a mixture of berries
(including strawberries).19 Conversely, a range of high polyphenol fruits in both mice and
human models appear to have the ability to significantly alter the gut microbiota
composition in ways that may benefit the host.9,11,16,134 Notably, strawberry powder
supplementation (~167 g fresh strawberry) for 37 days increased -diversity and
alleviated dysbiosis by increasing probiotic bacteria (e.g. Bifidobacterium and
Lactobacillus) in mice with colitis. Additionally, strawberry powder (~160 g fresh
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strawberry) administered for 10 weeks was shown to increase Bifidobacterium in
diabetic mice. However, 2-weeks of strawberry consumption at the current dose (~125 g
fresh strawberry) did not alter the microbiota in postmenopausal women in a
statistically significant way.
The finding that there was no significant change in bacteria and diversity could be due
to sample size, supplement dosing, study duration, and interindividual variability in
bacteria composition. The study’s small sample size resulted in less accurate mean
values, and therefore less power to detect change. The lack of change possibly indicates
that the supplement dose was not high enough to detect significant change or that the
study duration was not sufficiently long. It is possible that a higher dose of strawberry or
a longer duration may encourage growth of different strains of bacteria that may have
been reflected in significant values and an increased alpha diversity. Research indicates
that freeze dried blueberries at a dose of 25 g (375 mg anthocyanins) for six weeks
results in significant changes in the gut composition.16 Considering that blueberries have
a much higher polyphenol concentration than strawberries, a dose of strawberries at
least this amount (while adjusting for density) should be implemented in future studies.
Additionally, the variability in gut composition between participants renders it difficult
to measure the true efficacy of the intervention. While the increase in Bifidobacterium
and Lactobacillus was insignificant, participants eliminated polyphenol foods from their
diet, so in theory, the slight increase in these beneficial bacterial could have resulted
from the strawberry. These preliminary findings, while valuable to shape future research
methods, cannot be generalized to the current target population.
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While no significant shifts in the F:B ratio were measured, it is important to note that we
were not able to measure total bacteria count. It is known that bacteria such as
Firmicutes and Bacteroidetes ferment plant-based substances and thus it is likely that
introducing FDSP into the diet increased the total bacteria load. Bacterial load can vary
greatly in response to factors such as diet and health84; a recent study published in
Nature found that healthy individuals compared to unhealthy individuals have one order
of magnitude higher bacteria load.135 This indicates that given a longer length of an
increased polyphenol diet, a significant effect on the gut microbiota may have occurred–
at some point, there may have been enough growth of total bacteria populations to
change the ratio significantly.
With this consideration, the association between a higher F:B ratio and obesity may be a
spurious conclusion, since it does not disclose information about total bacteria
populations or changes in these populations. The ratio only reveals that the relative
population growth or decline causes one phylum of bacteria to grow or decline to shift
the ratio, but there is no way to know, for example, the rate at which Firmicutes is
changing compared to Bacteroidetes. It could be that both phyla increased but one just
increased faster than the other, resulting in a shift in the ratio.
Theory says that obese individuals have a high baseline F:B ratio,48 but considering the
current data, since all we could test for is ratio, an alternative consideration may be that
the unhealthy gut conditions associated with obesity simply lowers overall populations
of bacteria. It may also be that diets that generally lead to obesity may be less favorable
to large populations of gut bacteria as opposed to plant-based diets that encourage
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fermentation and therefore larger populations of bacteria. Total bacteria population
numbers may be a better indicator of gut health than ratio,135 which may explain why
discrepancies regarding the F:B ratio exist in the literature. Recent literature supports
the observation that there is currently no taxonomic signature of obesity that exists in
the gut microbiome.53
Furthermore, the F:B ratio has been shown to both negatively and positively correlate
with BMI,53,136 so perhaps limiting the study population by this measure is premature. It
may be beneficial to determine at what dose strawberry polyphenols affect the gut
microbiota in postmenopausal women before restricting the population by weight.

5.4

Conclusion

In the context of gut health, studies have emphasized the importance of analyzing
whole diets versus evaluating changes in microbial populations from isolated
compounds. Foods contain different mixtures of fiber and polyphenols, and results from
studies analyzing single compounds could reach different conclusions from conclusions
drawn from the context of real life.137 As such, the strawberries may work synergistically
via its numerous health promoting compounds to confer health to the host through the
gut. For this reason, this study analyzed how whole strawberry consumption in a diet
may favorable alter the gut microbiota.
In addition, while there is a wealth of literature supporting the association between
ratios of bacteria phyla and obesity, the pathogenesis of obesity is multifactorial and is
likely more complicated than a simple shift in Firmicutes and Bacteroidetes. Much of the
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supporting evidence linking the F:B ratio to obesity was from murine studies which
complicates the extrapolation of mouse research to humans. It could be more beneficial
to first look at the absolute quantity of microbes and evaluate how these numbers
correlate with disease and subsequently see how different species and their metabolites
influence health.

5.5

Strengths and Limitations

This study was short in duration to minimize attrition and maximize participation.
Another strength is that the free-living nature of the study closely mimics reality which
allows the results to be better generalized to other populations. Additionally,
participants were given individually labeled, pre-packaged, single serving strawberry
powder for each day of the week. This enabled participants to easily keep track of their
intake, therefore ensuring they consumed the proper quantity of strawberry each day.
Another strength is that the portion size and type of strawberries (fresh and frozen
cultivars available throughout the US) as well as the concentration and type of
polyphenols was likely consistent within each individual and between subjects since
participants were consuming homogenized powder from the same batch. Further,
uBiome was utilized for all stool sample processing making it possible to expand the
study to Fresno county. Samples were shipped directly to the lab, as opposed to
processing at Cal Poly, giving the study a high degree of flexibility. Outsourcing sample
analysis also decreased chances of sample contamination by human error and
minimized human exposure to potentially harmful pathogens. Lastly, a washout period
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was utilized to standardize the detection of the effect of the strawberry powder by
reducing inter-subject variation.
This study is limited by the relatively small sample size – a larger sample size may have
yielded more power to detect significant results. However, pilot studies do not have a
defined sample size. Additionally, no control group was used so we cannot conclude for
certain the true effect of the treatment. A cross-over RCT would be the preferred study
design for a diet intervention of this type. Additionally, a more restricted diet as
opposed to free-living may have better standardized detection of changes by reducing
intersubject variability. Finally, the sample of feces collected was very small and may not
have been representative of the overall proportion of feces to bacteria that inhabit the
intestine.

5.6

Future Research

As this is a pilot study, it was designed as a preliminary study for a larger 18-week study
being conducted by future graduate students in the department of Food Science and
Nutrition at Cal Poly-SLO. The 18-week study will look at the effect of strawberries on
gut health in addition to their impact on heart health. The methodology tested in this
research will have established a more seamless process to recruit and screen
participants, was effective in troubleshooting any equipment problems, and familiarized
the study team with procedures. Furthermore, a pilot study enabled the main study to
run more smoothly by solving many of the minor problems encountered during the pilot
phase.
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In addition, the data generated gave a first impression of the variability of the data and
established feasibility given the population. This study provided the opportunity to
evaluate the representativeness of the sample in addition to the relative cost and time
necessary to conduct it. Even with the small sample size, the data can still be used to
draw basic conclusions to help inform the 18-week study. Since we used resources to
minimize labor and cost, the 18-week study with better reflect any potential effect the
strawberries may have on heart and gut health.
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APPENDICES
A. Nutrient composition of freeze-dried strawberry powder*
Nutrient
Proximates
Water (g)
Ash (g)
Calories (kcal)
Calories from Fat (kcal)
Protein (g)
Total lipid (g)
Carbohydrate (g)
Dietary Fiber (g)
Sugars, total (g)
Fructose (g)
Glucose (g)
Sucrose (g)
Minerals
Calcium (ppm)
Iron (ppm)
Potassium (ppm)
Sodium (ppm)
Vitamins
Vitamin C (mg)
Thiamin (mg)
Riboflavin (mg)
Niacin (mg)
Pantothenic acid (mg)
Vitamin B6 (mg)
Folate (mg)
* Source: California Strawberry Commission
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Per 100 g
10.3
4.31
350
15.2
6.83
1.7
76.9
14.3
61.2
28.8
24.4
8.1
1730
32.1
16800
102
346
0.06
0.048
0.4
0.115
0.0207
0.0399

B. Polyphenol composition of freeze-dried strawberry powder. Estimated
values*
Per 13 g
521.58
40.04
10.66

(mg)1

Total phenolics
Total anthocyanins (mg)2
Ellagic acid (mg)
*Adapted from Basu, 2009138
1expressed as mg gallic acid equivalents
2expressed as mg cyanidin-3-glucoside
equivalents
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C. List of food sources high in probiotics and polyphenols
Strawberries and Gut Health in Post-menopausal Women

Dietary Intake Directions for Washout
& Supplement Intervention Periods
While participating in this study, please maintain your current diet pattern, but avoid dietary sources
that are high in polyphenols and probiotics. In addition, do not consume greater than 5 servings a week
of soy, green tea, or cocoa products. In addition to avoiding the foods listed below, please adhere to the
following directions during your participation in this study:
● Do not smoke or consume tobacco
● One alcoholic beverage is equal to 12 oz beer, 5 oz wine, and 1.5 oz distilled spirit
● Do not follow an energy restricted or low-fat diet (<20% energy from fat)
Probiotic Foods
AVOID
Yogurt (limit to ½ cup or 4
ounces per day)

Alternatives
Yogurts that do not
contain 'Live & Active
Cultures' seal

Kefir

Avoid

Kombucha tea

Avoid

Polyphenol Sources
(other than what is provided during diet
intervention)
AVOID
Alternatives
Alcohol - wine & beer
(limit to <5 servings per
Apple juice, Pineapple
week)
Juice, Grape Juice
Green Tea, Black Tea,
Oolong Tea
Chamomile tea
Cocoa Powder and
associated products: highcocoa, polyphenol-rich
White Chocolate
chocolate (i.e. semi-sweet
chocolate; dark chocolate=
>60% chocolate)
Melons (cantaloupe,
honeydew, watermelon),
Kiwi (green), Mango,
Pineapple, Apples, Figs,
Canned Peaches

Tempeh

Avoid

Berries: (strawberries,
blueberries, blackberries,
cranberries, raspberries,
etc.) (limit to ≤ 1 cup/wk)

Cultured Condiments
(horseradish, pickle relish,
sauerkraut)

Avoid

Plums

Persimmons

Natto

Avoid

Grapes (red & black)

Grapes (green), Dried
Cranberries, Raisins

Probiotic and Prebiotic
Supplements

Avoid

Pomegranates (≤1/wk)

Bananas

Cherries
Nuts (pecans, hazelnut,
walnut) *OK to consume if
already part of daily diet

Fruit jellies & jams
Almonds, Cashews,
Macadamia nuts,
Peanuts, Pistachios
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D. Example template of 3-Day Food Record
Strawberries and Gut Health in Postmenopausal Women

3-Day Diet Record

Study ID: _______________
Date: __________________

At the end of each washout and diet intervention period, use this worksheet to record (in detail) all foods and beverages you
consume throughout the day.
Instructions to Remember:
1. Start a new page for each day of recording. Note: the exact days that you record your diet intake should correspond to the
exact days you record your physical activity on the 3-Day Physical Activity record forms.
2. Maintain your current eating patterns. Any foods recorded on this form should represent your usual intake.
3. List any vitamin, mineral, or other supplements taken on the back side of this worksheet.
*Do not forget to include water and alcohol in this record.
*Examples are shown in the shaded rows.
Time

8:15
am
8:15
am

Brand/Source
(manufacturer, if
available)

Food or Beverage Item
(Name and Description)

Meal/Snack

Preparation
Method
(bake, boil, fry,
etc.)

Amount/Wt
(ounces, grams, fluid
ounces, cups, tsp, Tbsp)

Total Cereal

General Mills

NA

1 oz/1 cup

Light Soy milk, vanilla

Silk

NA

4 fl oz/.5 cup
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E. Example template of 3-Day Physical Activity Record
Strawberries and Gut Health in Postmenopausal Women

3-Day Physical Activity Record

Study ID: _______________
Date: __________________

Use this worksheet to record any physical activity you engage in during the last week of the washout and/or diet intervention study
phases (depending on which study phase you are in).

Instructions:
1. Maintain your current level of physical activity. Any activity recorded on this form should represent your usual level/intensity
of exercise.
2. Start a new page for each day of recording.
3. Activity record should correspond to the exact days of the 3-Day Diet Record.
4. Please refer to the definitions of low, moderate, and high intensity (shown below) when completing your records.
*

Moderate Activity
requires a moderate amount of effort and
causes increased breathing with a
moderate increase in heart rate
− walking briskly
− heavy cleaning (washing windows,
vacuuming, mopping)
− mowing lawn
− bicycling lightly
− hiking
− recreational swimming

Low Activity
requires minimal to no effort with no
change in heart rate
− walking slowly
− sitting at computer
− standing light work (cooking,
washing dishes)
− stretching
− fishing
− playing catch
− light yard/house work

High Activity
requires a large amount of effort and
causes rapid breathing and a substantial
increase in heart rate
− jogging/running
− mountain climbing
− bicycling more than 10mph
− step aerobics
− jump roping
− treading water

Strawberries and Gut Health in Postmenopausal Women

3-Day Physical Activity Record

Study ID: _______________
Date: __________________

Examples are shown in the shaded rows.
Time of Day

Physical Activity
performed

Description of Activity

Intensity (*low, mod.,
high)

Duration

8:00am

Jogging

Jogged around
neighborhood

Moderate

15 minutes
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